+ Anti-retroviral drugs

SECTION27, TAC and MSF South Africa call on the EU and India to stop the threats to people’s lives

The Treatment Action Campaign (TAC), SECTION27 and Médecins Sans Frontières / Doctors Without Borders (MSF) South Africa voice support for their partners across the world opposing provisions in a proposed free trade agreement (FTA) between India and the European Union (EU) that threaten the sustainable supply of affordable medicines to millions of people in the developing world.

SECTION27 and TAC applaud successful ARV medicine tender

SECTION27 and TAC applauds the successful ARV medicine tender – but call for continued actions to drive prices of essential medicines down further.

SECTION27 and TAC applaud the Minister of Health and his team at the Department of Health (DoH) for their part in conceptualising, implementing and concluding a successful antiretroviral (ARV) medicine tender. Announced yesterday, the 2010 tender – for the period 1 January 2011 to 31 December 2012 – will see the state procuring ARV medicines at or about the best prices available globally.

Concerns regarding Indian trade negotiations with EU

Letter to the High Commissioner for India to South Africa: Our concerns regarding Indian trade negotiations with EU.
This letter explains that the prospect of making new ARVs available in South Africa at affordable prices is under threat because of events unfolding in India. In particular, pressure is being applied by the European Union on the Indian government to sign a bilateral trade agreement that will stifle competition on essential medicines still under patent.

The ALP welcomes aspects of the 2010/2011

The AIDS Law Project (ALP) welcomes those aspects of the 2010/2011 budget that deal with health tabled by Minister of Finance Pravin Gordhan on 17 February 2010.

BEMF 2nd meeting: The treatment guidelines and the ARV tender – 5 February 2010

BEMF 2nd meeting: The treatment guidelines and the ARV tender – 5 February 2010.
Presentations:

  • Introductory Notes – Nathan Geffen
  • The New Treatment Guidelines – Francois Venter
  • Procuring High Quality ARVs at Internationally Competitive Prices – Vishal Brinjlal
  • Legislative Framework for Procurement – Jonathan Berger